BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27328830)

  • 1. European Commission tables scientific criteria for endocrine disruptors.
    Watson R
    BMJ; 2016 Jun; 353():i3459. PubMed ID: 27328830
    [No Abstract]   [Full Text] [Related]  

  • 2. Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles.
    Dietrich D; von Aulock S; Marquardt HW; Blaauboer BJ; Dekant W; Kehrer J; Hengstler JG; Collier AC; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Arch Toxicol; 2013 Sep; 87(9):1739-41. PubMed ID: 23979651
    [No Abstract]   [Full Text] [Related]  

  • 3. European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.
    Perharič L; Fatur T; Drofenik J
    Arh Hig Rada Toksikol; 2016 Jun; 67(2):99-105. PubMed ID: 27331297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen OP; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes A; Gooderham N; Harvey A
    Toxicol In Vitro; 2013 Oct; 27(7):2110-4. PubMed ID: 23850741
    [No Abstract]   [Full Text] [Related]  

  • 6. EDCs: regulation still lagging behind evidence.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2019 May; 7(5):325. PubMed ID: 30954435
    [No Abstract]   [Full Text] [Related]  

  • 7. Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.
    Bergman Å; Andersson AM; Becher G; van den Berg M; Blumberg B; Bjerregaard P; Bornehag CG; Bornman R; Brandt I; Brian JV; Casey SC; Fowler PA; Frouin H; Giudice LC; Iguchi T; Hass U; Jobling S; Juul A; Kidd KA; Kortenkamp A; Lind M; Martin OV; Muir D; Ochieng R; Olea N; Norrgren L; Ropstad E; Ross PS; Rudén C; Scheringer M; Skakkebaek NE; Söder O; Sonnenschein C; Soto A; Swan S; Toppari J; Tyler CR; Vandenberg LN; Vinggaard AM; Wiberg K; Zoeller RT
    Environ Health; 2013 Aug; 12():69. PubMed ID: 23981490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Food Chem Toxicol; 2013 Dec; 62():A1-4. PubMed ID: 23835284
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.
    Marx-Stoelting P; Niemann L; Ritz V; Ulbrich B; Gall A; Hirsch-Ernst KI; Pfeil R; Solecki R
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):590-604. PubMed ID: 25239592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of endocrine disrupting chemicals--introduction to this special issue.
    van Ravenzwaay B; Dekant W; Vrijhof H
    Toxicol Lett; 2013 Dec; 223(3):269-70. PubMed ID: 24140152
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification, assessment and management of "endocrine disruptors" in wildlife in the EU substance legislation--discussion paper from the German Federal Environment Agency (UBA).
    Frische T; Bachmann J; Frein D; Juffernholz T; Kehrer A; Klein A; Maack G; Stock F; Stolzenberg HC; Thierbach C; Walter-Rohde S
    Toxicol Lett; 2013 Dec; 223(3):306-9. PubMed ID: 23500481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The European Commission hides behind experts with conflicts of interest to delay, again, the regulation of endocrine disruptors].
    Romano Mozo D
    Arch Prev Riesgos Labor; 2014; 17(1):31-2. PubMed ID: 24458208
    [No Abstract]   [Full Text] [Related]  

  • 14. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
    Gori GB; Dekant W
    Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor: Re: Neurobehavioral Deficits, Diseases, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union.
    Middelbeek RJ; Veuger SA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L52-3. PubMed ID: 26047084
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".
    Rhomberg LR; Goodman JE; Foster WG; Borgert CJ; Van Der Kraak G
    Crit Rev Toxicol; 2012 Jul; 42(6):465-73. PubMed ID: 22630047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):317-20. PubMed ID: 23850959
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endocrine disrupters: from research to risk assessment].
    Mantovani A; La Rocca C; Maranghi F
    Epidemiol Prev; 2009; 33(1-2):5-7. PubMed ID: 19585867
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary exposure to endocrine-active pesticides: Conflicting opinions in a European workshop.
    Flynn K
    Environ Int; 2011 Jul; 37(5):980-90. PubMed ID: 21497907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.